This is to acknowledge that Giuseppe Cotellessa Attended a TwchTalk session entitled " Bridging Efficacy and Safety Through Advanced DMPK"/ Si attesta che Giuseppe Cotellessa ha partecipato a una sessione TwchTalk dal titolo "Collegare efficacia e sicurezza attraverso la DMPK avanzata" /#16/10/2026 ter
This is to acknowledge that Giuseppe Cotellessa Attended a TwchTalk session entitled " Bridging Efficacy and Safety Through Advanced DMPK" / Si attesta che Giuseppe Cotellessa ha partecipato a una sessione TwchTalk dal titolo "Collegare efficacia e sicurezza attraverso la DMPK avanzata" /#16/10/2026 ter Dott. Giuseppe Cotellessa Bridging Efficacy and Safety Through Advanced DMPK While ADME-related attrition has dramatically declined from roughly 40% in the 1980s and 90s to 10–15% today, sub-optimal DMPK properties remain a primary driver of drug candidate failure. This TechTalk explores how modern DMPK science serves as the foundational bridge between pharmacology and safety assessment, empowering teams to drive smarter, risk-informed candidate selection. Join industry experts Roger Melton and Dr. Matt Hutzler from Inotiv as they unpack the persistent hurdles of drug exposure, including dissolution, solubility, permeability, and first-pass metabolism and examine th...